As he weighs free agent offers this offseason, former Yankee Didi Gregorius is partnering with Johns Hopkins to encourage folks who have tested positive for coronavirus to enroll in a clinical trial for a new covid therapy.
Johns Hopkins wants to see if plasma drawn from an asymptomatic COVID-19 patient and injected into someone who has tested positive within 6 days could help that newly diagnosed patient recover faster.
Gregorius has a personal interest in this: His longtime kidney condition is an underlying condition that puts him more at risk for a particularly negative outcome should he contract COVID-19.
He spoke on "All Things Considered" about his Johns Hopkins partnership, what it was like play baseball during a pandemic and his feelings about his years with the Yankee.
Hear the interview below:
